219 related articles for article (PubMed ID: 3056253)
21. Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacin.
Bedard J; Chamberland S; Wong S; Schollaardt T; Bryan LE
Antimicrob Agents Chemother; 1989 Sep; 33(9):1457-64. PubMed ID: 2510591
[TBL] [Abstract][Full Text] [Related]
22. Active efflux of bile salts by Escherichia coli.
Thanassi DG; Cheng LW; Nikaido H
J Bacteriol; 1997 Apr; 179(8):2512-8. PubMed ID: 9098046
[TBL] [Abstract][Full Text] [Related]
23. Comparative aspects of the diffusion of norfloxacin, cefepime and spermine through the F porin channel of Enterobacter cloacae.
Chevalier J; Malléa M; Pagès JM
Biochem J; 2000 May; 348 Pt 1(Pt 1):223-7. PubMed ID: 10794735
[TBL] [Abstract][Full Text] [Related]
24. The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli.
Mortimer PG; Piddock LJ
J Antimicrob Chemother; 1993 Aug; 32(2):195-213. PubMed ID: 8226422
[TBL] [Abstract][Full Text] [Related]
25. Decreased permeability and enhanced proton-dependent active efflux in the development of resistance to quinolones in Morganella morganii.
Tavío MM; Vila J; Ruiz J; Martín Sánchez AM; Jiménez de Anta MT
Int J Antimicrob Agents; 2000 Mar; 14(2):157-60. PubMed ID: 10720807
[TBL] [Abstract][Full Text] [Related]
26. Activity of KB-5246 against outer membrane mutants of Escherichia coli and Salmonella typhimurium.
Kotera Y; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1990 Jul; 34(7):1323-5. PubMed ID: 2167038
[TBL] [Abstract][Full Text] [Related]
27. Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Périchon B; Courvalin P; Galimand M
Antimicrob Agents Chemother; 2007 Jul; 51(7):2464-9. PubMed ID: 17470656
[TBL] [Abstract][Full Text] [Related]
28. Energy-dependent accumulation of fluoroquinolones in quinolone-resistant Klebsiella pneumoniae strains.
Martínez-Martínez L; García I; Ballesta S; Benedí VJ; Hernández-Allés S; Pascual A
Antimicrob Agents Chemother; 1998 Jul; 42(7):1850-2. PubMed ID: 9661034
[TBL] [Abstract][Full Text] [Related]
29. Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway?
Griffiths NM; Hirst BH; Simmons NL
J Pharmacol Exp Ther; 1994 May; 269(2):496-502. PubMed ID: 8182517
[TBL] [Abstract][Full Text] [Related]
30. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
Smith JT
Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
[TBL] [Abstract][Full Text] [Related]
31. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar typhimurium.
Giraud E; Cloeckaert A; Kerboeuf D; Chaslus-Dancla E
Antimicrob Agents Chemother; 2000 May; 44(5):1223-8. PubMed ID: 10770755
[TBL] [Abstract][Full Text] [Related]
32. Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.
Knapp JS; Hale JA; Neal SW; Wintersheid K; Rice RJ; Whittington WL
Antimicrob Agents Chemother; 1995 Nov; 39(11):2442-5. PubMed ID: 8585723
[TBL] [Abstract][Full Text] [Related]
33. Functional mosaicism of membrane proteins in vesicles of Escherichia coli.
Adler LW; Rosen BP
J Bacteriol; 1977 Feb; 129(2):959-66. PubMed ID: 190212
[TBL] [Abstract][Full Text] [Related]
34. Active uptake of tetracycline by membrane vesicles from susceptible Escherichia coli.
McMurry LM; Cullinane JC; Petrucci RE; Levy SB
Antimicrob Agents Chemother; 1981 Sep; 20(3):307-13. PubMed ID: 7030198
[TBL] [Abstract][Full Text] [Related]
35. Transport of cyclic adenosine 3',5'-monophosphate across Escherichia coli vesicle membranes.
Goldenbaum PE; Hall GA
J Bacteriol; 1979 Nov; 140(2):459-67. PubMed ID: 227841
[TBL] [Abstract][Full Text] [Related]
36. Corneal and scleral permeability of quinolones--a pharmacokinetics study.
Tai MC; Lu DW; Chiang CH
J Ocul Pharmacol Ther; 2003 Dec; 19(6):547-54. PubMed ID: 14733712
[TBL] [Abstract][Full Text] [Related]
37. The fungus Pestalotiopsis guepini as a model for biotransformation of ciprofloxacin and norfloxacin.
Parshikov IA; Heinze TM; Moody JD; Freeman JP; Williams AJ; Sutherland JB
Appl Microbiol Biotechnol; 2001 Aug; 56(3-4):474-7. PubMed ID: 11549022
[TBL] [Abstract][Full Text] [Related]
38. In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
Obana Y; Nishino T
Drugs Exp Clin Res; 1989; 15(2):53-8. PubMed ID: 2661182
[TBL] [Abstract][Full Text] [Related]
39. Quinolone accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus.
McCaffrey C; Bertasso A; Pace J; Georgopapadakou NH
Antimicrob Agents Chemother; 1992 Aug; 36(8):1601-5. PubMed ID: 1416840
[TBL] [Abstract][Full Text] [Related]
40. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus.
Kaatz GW; Seo SM; Ruble CA
Antimicrob Agents Chemother; 1993 May; 37(5):1086-94. PubMed ID: 8517696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
